Overview
Aleodor Andea is a Dermatologist in Ann Arbor, Michigan. Dr. Andea is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. His top areas of expertise are Tieche-Jadassohn Nevus, Melanoma, Syringoma, and Basal Cell Skin Cancer.
His clinical research consists of co-authoring 70 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Eccrine Porocarcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
1500 E Medical Center Dr, Ann Arbor, MI 48109
2800 Plymouth Rd # 35, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Michigan Medical Center
Paul Harms is a Dermatologist in Ann Arbor, Michigan. Dr. Harms has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. His top areas of expertise are Merkel Cell Carcinoma, Eccrine Porocarcinoma, Tieche-Jadassohn Nevus, and Melanoma.
Regents Of The University Of Michigan
Kelly Harms is a Dermatologist in Ann Arbor, Michigan. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. Her top areas of expertise are Merkel Cell Carcinoma, Eccrine Porocarcinoma, Melanoma, and Basal Cell Skin Cancer. Dr. Harms is currently accepting new patients.
Regents Of The University Of Michigan
Christopher Bichakjian is a Dermatologist in Ann Arbor, Michigan. Dr. Bichakjian is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. His top areas of expertise are Merkel Cell Carcinoma, Basal Cell Skin Cancer, Melanoma, and Squamous Cell Skin Carcinoma. Dr. Bichakjian is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Tieche-Jadassohn NevusDr. Andea isElite. Learn about Tieche-Jadassohn Nevus.
- Distinguished
- Basal Cell Skin CancerDr. Andea isDistinguished. Learn about Basal Cell Skin Cancer.
- Eccrine PorocarcinomaDr. Andea isDistinguished. Learn about Eccrine Porocarcinoma.
- MelanomaDr. Andea isDistinguished. Learn about Melanoma.
- Multiple Familial TrichoepitheliomaDr. Andea isDistinguished. Learn about Multiple Familial Trichoepithelioma.
- Sebaceous AdenomaDr. Andea isDistinguished. Learn about Sebaceous Adenoma.
- Syringocystadenoma PapilliferumDr. Andea isDistinguished. Learn about Syringocystadenoma Papilliferum.
- Advanced
- AcrospiromaDr. Andea isAdvanced. Learn about Acrospiroma.
- Bowen's DiseaseDr. Andea isAdvanced. Learn about Bowen's Disease.
- Extramammary Paget DiseaseDr. Andea isAdvanced. Learn about Extramammary Paget Disease.
- Familial Atypical Multiple Mole Melanoma Syndrome
- Giant Congenital Melanocytic Nevus
- Giant Congenital NevusDr. Andea isAdvanced. Learn about Giant Congenital Nevus.
- Experienced
- Acrogeria, Gottron TypeDr. Andea isExperienced. Learn about Acrogeria, Gottron Type.
- Actinic KeratosisDr. Andea isExperienced. Learn about Actinic Keratosis.
- Bazex SyndromeDr. Andea isExperienced. Learn about Bazex Syndrome.
- Bullous PemphigoidDr. Andea isExperienced. Learn about Bullous Pemphigoid.
- Congenital Hypotrichosis MiliaDr. Andea isExperienced. Learn about Congenital Hypotrichosis Milia.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Andea isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).

